Short Interest in VWR Corp (VWR) Drops By 70.2%
VWR Corp (NASDAQ:VWR) saw a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 2,448,005 shares, a decline of 70.2% from the April 28th total of 8,222,154 shares. Approximately 2.9% of the company’s shares are sold short. Based on an average trading volume of 4,080,968 shares, the short-interest ratio is currently 0.6 days.
Several research analysts have weighed in on VWR shares. TheStreet upgraded VWR Corp from a “c” rating to a “b-” rating in a report on Wednesday, April 19th. Jefferies Group LLC boosted their price target on VWR Corp from $31.00 to $32.00 and gave the company a “buy” rating in a report on Monday, February 27th. Zacks Investment Research upgraded VWR Corp from a “hold” rating to a “buy” rating and set a $37.00 price target for the company in a report on Tuesday, May 16th. Finally, William Blair downgraded VWR Corp from an “outperform” rating to a “market perform” rating in a report on Monday, May 15th. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. VWR Corp currently has an average rating of “Hold” and a consensus price target of $32.67.
Shares of VWR Corp (NASDAQ:VWR) opened at 32.87 on Friday. The stock has a market capitalization of $4.33 billion, a PE ratio of 29.35 and a beta of 1.13. VWR Corp has a 52 week low of $24.42 and a 52 week high of $37.25. The stock’s 50 day moving average is $30.55 and its 200 day moving average is $27.48.
VWR Corp (NASDAQ:VWR) last issued its quarterly earnings results on Friday, May 5th. The medical research company reported $0.44 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.03. The business had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.11 billion. VWR Corp had a net margin of 3.89% and a return on equity of 16.06%. The firm’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.40 EPS. Analysts anticipate that VWR Corp will post $1.83 EPS for the current fiscal year.
Several large investors have recently modified their holdings of VWR. Vanguard Group Inc. increased its stake in shares of VWR Corp by 5.3% in the first quarter. Vanguard Group Inc. now owns 6,827,046 shares of the medical research company’s stock valued at $192,523,000 after buying an additional 345,117 shares during the period. Harris Associates L P increased its stake in VWR Corp by 43.3% in the first quarter. Harris Associates L P now owns 5,250,960 shares of the medical research company’s stock worth $148,077,000 after buying an additional 1,587,214 shares during the last quarter. JPMorgan Chase & Co. increased its stake in VWR Corp by 79.2% in the first quarter. JPMorgan Chase & Co. now owns 4,531,105 shares of the medical research company’s stock worth $127,777,000 after buying an additional 2,002,306 shares during the last quarter. Acadian Asset Management LLC increased its stake in VWR Corp by 16.7% in the first quarter. Acadian Asset Management LLC now owns 4,438,055 shares of the medical research company’s stock worth $125,152,000 after buying an additional 635,873 shares during the last quarter. Finally, BlackRock Inc. increased its stake in VWR Corp by 4,641.8% in the first quarter. BlackRock Inc. now owns 4,072,333 shares of the medical research company’s stock worth $114,840,000 after buying an additional 3,986,452 shares during the last quarter.
VWR Corp Company Profile
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.
Receive News & Ratings for VWR Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corp and related companies with MarketBeat.com's FREE daily email newsletter.